Prosight Management, LP: 13F holdings
CIK 16172012026Q2
| Positions | 36 |
|---|
| Reported value | $580.4m |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 36 (-10 vs prior quarter) |
|---|
| Reported value | $580.4m (-4.8%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| LKFT LAKEFRONT BIOTHERAPEUTICS NV | 2,043,344 | $61.3m | 10.6% |
| JANX JANUX THERAPEUTICS INC | 3,804,481 | $58.4m | 10.1% |
| NKTR NEKTAR THERAPEUTICS | 810,000 | $56.5m | 9.7% |
| BSX BOSTON SCIENTIFIC CORP | 1,270,273 | $54.2m | 9.3% |
| STTK SHATTUCK LABS INC | 5,957,877 | $41.3m | 7.1% |
| INSM INSMED INC | 375,609 | $40.0m | 6.9% |
| ALNY ALNYLAM PHARMACEUTICALS INC | 98,080 | $29.5m | 5.1% |
| SNDX SYNDAX PHARMACEUTICALS INC | 1,200,000 | $26.2m | 4.5% |
| KURA KURA ONCOLOGY INC | 2,021,964 | $22.2m | 3.8% |
| ALKERMES PLC | 394,389 | $20.7m | 3.6% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1617201")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples